November 28, 2016 Intec Pharma Enters into Agreement with the Michael J. Fox Foundation Around Its Phase III Trial Recruitment View Article
September 28, 2016 Foamix Pharmaceuticals Ltd. Announces Pricing of its $57 Million Follow-on Offering of Ordinary Shares View Article
September 12, 2016 Foamix Announces Positive Topline Results from Phase 2 Trial Evaluating FMX-103 Topical Minocycline Foam for Moderate-to-Severe Papulopustular Rosacea View Article
August 4, 2016 Intec Pharma to Pursue Development of Accordion Pill for Cannabinoid Therapies View Article
August 2, 2016 ReWalk Announces Launch of 522 Post-Market Study with Stanford University School of Medicine View Article
May 31, 2016 Foamix Pharmaceuticals Announces Publication of Abstract on FDX-104 in the Treatment of EGFRI Induced Rash for the 2016 ASCO Meeting View Article
